系统性红斑狼疮患者医保住院中四分之一在三十天内再入院
该数据库研究使用2014年美国 Medicare 20% 样本,比较 SLE、心衰(HF)与一般 Medicare 成人住院的30天再入院和死亡率。SLE 与 HF 观察再入院率均为24%,高于其他 Medicare 的16%;SLE 再入院在黑人、18-33岁及 ESRD 患者中更高。
要点
- SLE 与 HF 的30天观察再入院率均为24%,无统计学差异。
- SLE 再入院率在黑人(30%)、18-33岁(39%)和 ESRD(37%)中更高。
- SLE 再入院预防应关注年轻、ESRD 患者及护理过渡环节。
核心结论
- SLE 30天再入院率与 HF 相当,均为24%,高于其他 Medicare 住院的16%。
研究设计与样本
- 数据库研究,使用2014年美国 Medicare 全部成人住院的20%样本,按出院诊断分为 SLE、HF 及两者均无三组。
- 纳入要求活体出院且入院前有至少12个月 Medicare A/B 覆盖以评估基线协变量。
- 分析采用观察与预测概率及以患者为聚类单位的多变量 GEE 模型报告调整风险比(ARR)。
主要发现
- SLE 住院(n=10,868)更年轻、以女性为主、黑人比例更高、残疾及 Medicaid 或 ESRD 比例更高。
- SLE 与 HF 观察30天再入院率均为24%(p=0.6),均高于其他 Medicare 的16%(p<0.001)。
- SLE 和 HF 的调整再入院风险均升高,ARR 分别为1.08(95%CI 1.04-1.13)和1.11(95%CI 1.09-1.13)。
- SLE 再入院率黑人30%高于白人21%,18-33岁最高为39%,ESRD 为37%。
- 来自最不贫困社区的黑人 SLE 患者30天死亡率最高(9% vs 白人3%)。
临床怎么用
- 再入院预防项目应针对年轻、合并 ESRD 的 SLE 患者,并审视 SLE 诊疗与过渡期照护中的潜在差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thirty-day hospital readmissions in systemic lupus erythematosus (SLE) approach proportions in Medicare-reported conditions including heart failure (HF). We compared adjusted 30-day readmission and mortality among SLE, HF, and general Medicare to assess predictors informing readmission prevention. METHODS: This database study used a 20% sample of all US Medicare 2014 adult hospitalizations to compare risk of 30-day readmission and mortality among admissions with SLE, HF, and neither per discharge diagnoses (if both SLE and HF, classified as SLE). Inclusion required live discharge and ≥12 months of Medicare A/B before admission to assess baseline covariates including patient, geographic, and hospital factors. Analysis used observed and predicted probabilities, and multivariable GEE models clustered by patient to report adjusted risk ratios (ARRs) of 30-day readmission and mortality. RESULTS: SLE admissions (n=10,868) were younger, predominantly female, more likely to be Black, disabled, and have Medicaid or end-stage renal disease (ESRD). Observed 30-day readmissions of 24% were identical for SLE and HF (p = 0.6), and higher than other Medicare (16%, p < 0.001). Both SLE and HF had elevated readmission risk (ARR 1.08, (95% CI (1.04, 1.13)); 1.11, (1.09, 1.13)). SLE readmissions were higher for Black (30%) versus White (21%) populations, and highest in ages 18-33 (39%) and ESRD (37%). Admissions of Black patients with SLE from least disadvantaged neighborhoods had highest 30-day mortality (9% versus 3% White). CONCLUSION: Thirty-day SLE readmissions rivaled HF at 24%. Readmission prevention programs should engage young, ESRD patients with SLE and examine potential causal gaps in SLE care and transitions.
引用
- Bartels CM, Chodara A, Chen Y, et al. One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days. Semin Arthritis Rheum. 2021. PMID: 33813261. doi:10.1016/j.semarthrit.2021.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。